National Institute of Dental and Craniofacial Research; Amended Notice of Meeting, 3933 [2024-01129]
Download as PDF
Federal Register / Vol. 89, No. 14 / Monday, January 22, 2024 / Notices
Administered Diagnostics for Hepatitis B,
Hepatitis C, and HIV (Topic 127).
Date: February 15–16, 2024.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Rockville, MD
20892 (Video Assisted Meeting).
Contact Person: Stephen A. Gallo, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601
Fishers Lane, MSC 9834, Rockville, MD
20852, (240) 669–2858, steve.gallo@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: January 16, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–01045 Filed 1–19–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of
Closed Meeting
ddrumheller on DSK120RN23PROD with NOTICES1
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel; PK/PD of
mTOR Inhibitors in Aging.
Date: March 5, 2024.
Time: 12:30 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, 7201 Wisconsin Avenue,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Mariel Jais, PharmD,
Scientific Review Officer, Scientific Review
Branch, National Institute on Aging, 7201
Wisconsin Avenue, Gateway Bldg., Suite
2E400, Bethesda, MD 20892, (301) 594–2614,
mariel.jais@nih.gov.
VerDate Sep<11>2014
18:02 Jan 19, 2024
Jkt 262001
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
Dated: January 16, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–01047 Filed 1–19–24; 8:45 am]
BILLING CODE 4140–01–P
3933
6001 Executive Boulevard, Rockville, MD
20852, (301) 827–0399, ereifejes@
mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program No. 93.242, Mental Health Research
Grants, National Institutes of Health, HHS)
Dated: January 17, 2024.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–01130 Filed 1–19–24; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4140–01–P
National Institutes of Health
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institute of Mental Health;
Notice of Closed Meetings
National Institutes of Health
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Mental Health Special Emphasis Panel;
BRAIN Initiative: Reagent Resources for
Brain Cell Type-Specific Access and
Manipulation to Broaden Distribution of
Enabling Technologies for Neuroscience (U24
Clinical Trial Not Allowed).
Date: February 20, 2024.
Time: 12:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852.
Contact Person: Evon Abisaid, Ph.D.,
Scientific Review Officer, Division of
Extramural Activities, National Institute of
Mental Health, National Institutes of Health,
6001 Executive Boulevard, Rockville, MD
20852, (301) 827–0399, ereifejes@
mail.nih.gov.
Name of Committee: National Institute of
Mental Health Special Emphasis Panel;
Instrumentation Program (S10 Clinical Trial
Not Allowed).
Date: February 26, 2024.
Time: 12:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852.
Contact Person: Evon Abisaid, Ph.D.,
Scientific Review Officer, Division of
Extramural Activities, National Institute of
Mental Health, National Institutes of Health,
PO 00000
Frm 00029
Fmt 4703
Sfmt 4703
National Institute of Dental and
Craniofacial Research; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the National Institute of
Dental and Craniofacial Research
Special Emphasis Panel Developing
Salivary Components as Therapeutics
for Oral Health, March 7, 2024, 12:30
p.m. to March 7, 2024, 5 p.m., National
Institute of Dental and Craniofacial
Research, 6701 Democracy Blvd.,
Bethesda, MD 20817 which was
published in the Federal Register on
December 18, 2023, FR Doc. 2023–
27744, 88 FR 87444.
The meeting time has changed from
12:30 p.m. to 5 p.m. to 10:30 a.m. to 5
p.m. The date of the meeting and the
location remain the same. The meeting
is closed to the public.
Dated: January 17, 2024.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–01129 Filed 1–19–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meetings
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
E:\FR\FM\22JAN1.SGM
22JAN1
Agencies
[Federal Register Volume 89, Number 14 (Monday, January 22, 2024)]
[Notices]
[Page 3933]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-01129]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Dental and Craniofacial Research; Amended
Notice of Meeting
Notice is hereby given of a change in the meeting of the National
Institute of Dental and Craniofacial Research Special Emphasis Panel
Developing Salivary Components as Therapeutics for Oral Health, March
7, 2024, 12:30 p.m. to March 7, 2024, 5 p.m., National Institute of
Dental and Craniofacial Research, 6701 Democracy Blvd., Bethesda, MD
20817 which was published in the Federal Register on December 18, 2023,
FR Doc. 2023-27744, 88 FR 87444.
The meeting time has changed from 12:30 p.m. to 5 p.m. to 10:30
a.m. to 5 p.m. The date of the meeting and the location remain the
same. The meeting is closed to the public.
Dated: January 17, 2024.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-01129 Filed 1-19-24; 8:45 am]
BILLING CODE 4140-01-P